Avita Medical | Pasivo Circulante



Current Liabilities Cambio Fecha
Adcock Ingram Holdings ZAR 2.81B 279.84M 2024-12
Celltrion KRW 3.4T 3.16T 2025-03
Clinuvel Pharmaceuticals AUD 25.21M 4.17M 2024-06
Cochlear AUD 626.1M 5.4M 2024-12
CSL USD 6.07B 1.12B 2024-12
Cspc Pharmaceutical CNY 9.63B 801.28M 2024-12
Dianthus Therapeutics USD 18.45M 2.74M 2024-12
Divis Laboratories Ltd 14.52B 1.61B 2025-03
Kangmei Pharma CNY 4.91B 208.41M 2024-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 156.65M 115.81M 2024-12
Malin Corporation EUR 1000K 500K 2024-12
Mayne Pharma AUD 313.94M 18.28M 2024-06
Medical Developments International AUD 6.37M 3.17M 2024-12
Nanosonics AUD 38.76M 6.53M 2024-12
Neuren Pharmaceuticals AUD 45.76M 36.79M 2024-12
Organigram Holdings CAD 68.96M 15.64M 2024-12
Pacific Edge NZD 8.43M 109K 2024-09
Paradigm Biopharmaceuticals AUD 1.08M 2.28M 2024-12
Pharma Mar EUR 79.49M 3.2M 2025-03
Polynovo AUD 23.25M 9.22M 2024-06
PYC Therapeutics AUD 11.38M 2.27M 2024-12
Qiagen NV USD 516.94M 26.68M 2025-03
Ramsay Health Care AUD 3.72B 465.1M 2024-12
ResMed USD 851.96M 52.12M 2024-12
Sartorius EUR 1.48B 36.8M 2025-03
Sino Biopharmaceutical CNY 19.56B 2.39B 2024-12
Telix Pharmaceuticals AUD 330.91M 72.54M 2024-12
Tilray USD 278.52M 15.02M 2024-11
Zz Pientze Pharmaceu 2.32B 49.86M 2025-03



Avita Medical Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jun 2025.